Knowledge of CYP2C9 and VKORC1 genotype can improve dosing of warfarin.

被引：0
|
作者：
Kim, M.
Huang, S.
Frueh, F.
Rahman, A.
Burckart, G. J.
Thummel, K. E.
Lesko, L. J.
机构：
[1] Univ So Calif, US FDA, Silver Spring, MD USA
[2] Washington Univ, US FDA, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] VKORC1 and CYP2C9 Genotype Variations in Relation to Warfarin Dosing in Korean Stroke Patients
    Park, Sea Mi
    Lee, Jong-Keuk
    Chun, Sa Il
    Lee, Hae In
    Kwon, Sun U.
    Kang, Dong-Wha
    Kim, Jong S.
    JOURNAL OF STROKE, 2013, 15 (02) : 115 - 121
  • [2] Genotype of the VKORC1 and CYP2C9 genes in the individual response to warfarin
    Esperon, Patricia
    Raggio, Victor
    Goyeneche, Lucia
    Lorenzo, Mariana
    Taub, Irene
    Stoll, Mario
    REVISTA MEDICA DEL URUGUAY, 2008, 24 (04): : 266 - 276
  • [3] A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 640 - 648
  • [4] Warfarin sensitivity and CYP2C9 and VKORC1 genes
    Bukaveckas, Bonny Lewis
    INFLAMMATION RESEARCH, 2007, 56 : S223 - S224
  • [5] VKORC1, APOE, CYP2C9 variants and their influences on warfarin dosing in African Americans
    Schelleman, H.
    Chen, Z.
    Kealey, C.
    Whitehead, A. S.
    Christie, J.
    Price, M.
    Brensinger, C. M.
    Newcomb, C. W.
    Thorn, C. F.
    Samaha, F. F.
    Kimmel, S. E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S25 - S26
  • [6] Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
    Flockhart, David A.
    O'Kane, Dennis
    Williams, Marc S.
    Watson, Michael S.
    Flockhart, David A.
    Gage, Brian
    Gandolfi, Roy
    King, Richard
    Lyon, Elaine
    Nussbaum, Robert
    O'Kane, Dennis
    Schulman, Kevin
    Veenstra, David
    Williams, Marc S.
    Watson, Michael S.
    GENETICS IN MEDICINE, 2008, 10 (02) : 139 - 150
  • [7] Analytical Validation of CYP2C9 and VKORC1 Genotyping for Warfarin Dosing by an Automated Microarray System
    Murugesan, G.
    Lyon, K.
    Smith, A.
    Wu, A. H.
    Tubbs, R. R.
    Kottke-Marchant, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 566 - 566
  • [8] VKORC1 and CYP2C9 genotype distribution in Asian countries
    Gaikwad, Tejasvita
    Ghosh, Kanjaksha
    Shetty, Shrimati
    THROMBOSIS RESEARCH, 2014, 134 (03) : 537 - 544
  • [9] Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
    Johnson, J. A.
    Gong, L.
    Whirl-Carrillo, M.
    Gage, B. F.
    Scott, S. A.
    Stein, C. M.
    Anderson, J. L.
    Kimmel, S. E.
    Lee, M. T. M.
    Pirmohamed, M.
    Wadelius, M.
    Klein, T. E.
    Altman, R. B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (04) : 625 - 629
  • [10] Same day dosing of Warfarin patients using an expanded CYP2C9 and VKORC1 panel
    Vairavan, R.
    Phillips, M. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05): : 661 - 661
12345